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Reducing Unnecessary Phlebotomy Testing Using a Clinical Decision Support System 
Abstract 
Background: Overuse of phlebotomy testing offers little to improve patient outcomes. Reducing 
unnecessary phlebotomy tests can cut costs without compromising quality.  
Purpose: To determine the effectiveness of a clinical decision support system (CDSS) on 
reducing unnecessary type and screen tests, estimate the cost saved by the CDSS 
implementation, and describe the unnecessary ordering practices by provider type. 
Methods: Our study used a separate-sample pretest posttest design at a mid-Atlantic academic 
medical center to examine the number of unnecessary type and screen tests three months before 
and after CDSS implementation. A CDSS was embedded in our electronic health record. The 
CDSS appears when a type and screen is ordered informing the provider of the date and time the 
current test expires. Cost savings was estimated using time-driven activity-based costing. Pre-
intervention (801 tests) and post-intervention (801 tests) periods were used to describe ordering 
practices by provider type. 
Results: There were a total of 26,206 pre- and 25,053 post-intervention specimens. Significantly 
fewer unnecessary type and screen tests were ordered after the intervention (12.3%, n=3,073) 
than before (14.1%, n=3,691; p<0.001). The results demonstrated an estimated yearly savings of 
$142,612 after CDSS implementation. The majority of the tests were ordered by physicians 
(85.3% before and 83.1% after the intervention) compared to advanced practice nurses and 
physician assistants.  
Conclusions: Our study demonstrated that a CDSS impacted a variety of provider types, reduced 
unnecessary phlebotomy tests, and decrease annual costs. Interventions such as education, audits, 
and feedback are recommended to further reduce unnecessary ordering practices. 





Type and screen testing is used to determine blood compatibility and to identify clinically 
significant antibodies affecting blood transfusion compatibility. Our blood bank laboratory 
observed type and screen tests were often unnecessarily ordered in our organization. Type and 
screen tests are active for three days from the date the specimen is collected, yet many patients 
receive orders for repeat testing well in advance of the sample’s expiration without any medical 
need. 
Throughout health care unnecessary testing is time consuming for patients and staff, 
labor intensive, and does not contribute to improved outcomes (Attali et al., 2006; Konger et al., 
2016; Krasowski et al., 2015, Mafi et al., 2017)). It is estimated that $65 billion is spent to 
perform over 4 billion laboratory tests each year in the United States (Alexander, 2012). Low-
cost, high-frequency tests are ordered recurrently, unnecessarily, and contribute to the high cost 
of health care. 
Background 
Overutilization has been cited as the most significant contributor to the high cost of 
healthcare in America (Emanuel & Fuchs, 2008) and is not consistent with the Institute of 
Medicine’s aims to make healthcare safe, effective, efficient, timely, and patient-centered. The 
American Board of Internal Medicine launched Choosing Wisely, a national campaign in 2012 to 
address unnecessary testing (American Board of Internal Medicine Foundation. Choosing 
Wisely, n.d.).  
Unnecessary phlebotomy testing is defined as “tests that are ordered but not indicated,” 
(Zhi, Ding, Theisen-Toupal, Whelan, and Arnaout, 2013, p.e78962). Unnecessary phlebotomy 
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testing can cause patient discomfort and lead to hospital-acquired anemia and the need for 
possible blood transfusion (Koch et al., 2015; Thavendiranathan, Baggai, Ebidia, Detsky, & 
Choudhry, 2005). Unnecessary testing is ineffective because it does not provide valuable 
information for provider decision-making. Factors leading to unnecessary testing include: 
multiple providers ordering for the same patient, differing levels of provider training and 
experience, ordering incorrect testing, use of recurring orders that are not reviewed for necessity, 
and tests ordered before a clinical change could occur (Konger et al., 2016). 
It is estimated that 4-6 billion laboratory and pathology tests (Wians & Gill, 2013; Zhi, 
Ding, Theisen-Toupal, Whelan, & Arnaout, 2013) occur each year accounting for 4% of annual 
healthcare costs (Hanson & Plumhoff, 2012). As a value-based system in healthcare continues to 
evolve, providers and healthcare organizations need to explore opportunities to reduce non- 
value-added care without compromising quality. Ensuring that the correct test is ordered for the 
correct patient at the correct time is challenging for the following reasons: traditional routine 
ordering practices, defensive medicine to avoid possible litigation, ease of ordering lab work 
over the effort to investigate the need for a repeated test, habitual ordering, and lack of awareness 
of cost and patient impact of testing redundancy (Attali et al., 2006; Bourgault, 2018; Konger et 
al., 2016; Thakkar et al., 2015). In addition, many providers are uncertain when a type and screen 
test will expire, and do not want to be forced to accept uncrossmatched blood for a transfusion 
due to an expired specimen. 
To promote appropriate, evidence-based test ordering, clinical decision support systems 
(CDSSs) with specific patient information are embedded in the electronic health record (EHR). 
By filling a knowledge gap at the time of ordering, CDSS is known to improve adherence to 
ordering guidelines and reduce both direct and consequential costs of overutilization (Delvaux et 
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al., 2017). Adoption of CDSSs has been successful in reducing unnecessary radiologic imaging, 
overutilization of antibiotics, and Clostridium dificile testing (Blackmore et al., 2011; Forrest et 
al., 2014; White et al., 2017). 
Purpose 
The purpose of our study was to determine the effectiveness of a CDSS in decreasing the 
number of unnecessary type and screen tests. We also estimated the cost of unnecessary tests 
before and after implementation of the CDSS and described the unnecessary ordering practices 
by provider type. Our long-term purpose was to improve phlebotomy ordering practices by all 
provider types to reduce unnecessary testing and overutilization. 
Methods 
Research Design, Sample, Setting 
We used a separate-sample pretest posttest design, approved as an expedited review by 
the Institutional Review Board (IRB00175556) at our large academic medical center in the Mid-
Atlantic region. The design was chosen to determine the effect of a CDSS had on unnecessary 
type and screen ordering practices.  
Our Transfusion Medicine laboratory processes approximately 8,000 type and screen 
specimens from inpatient and outpatient locations each month. Among 49 inpatient care units, 30 
units use phlebotomists to draw the majority of specimens and 19 units use nurses to draw the 
specimens. Specimens rejected for not meeting acceptable specimen criteria were excluded. 
Reasons for excluding specimens were: labeling errors, collection errors, handling errors, 
contaminated specimen, or incorrect test requested. All 49 inpatient units were included in the 
review of provider ordering practices that included physicians, advanced practice nurses 
(APRNs), and physician assistants (PAs). 
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Study Sample Size 
The total number of appropriate and unnecessary type and screen tests was collected for 
three months before and three months after implementation of the CDSS. To estimate cost, we 
used the total number of unnecessary type and screens from both the pre- and post-CDSS 
implementation data collection periods. To describe the type of providers and ordering practices, 
we systematically selected 801 unnecessary type and screen specimens from the three month pre-
CDSS (267 samples x 3 months = 801) and the three month post-CDSS (267 samples x 3 months 
= 801) for a total of 1,602 specimens.   
Clinical Decision Support System 
CDSSs are EHR applications that use specific patient information to assist health care 
professionals in decision-making to improve care. Current literature has not assessed the effects 
of a CDSS before and after implementation when applied specifically to type and screen tests.  
Our department of Pathology’s informatics team developed the CDSS to assist providers 
to make decisions about type and screen testing. Evidence in the literature demonstrates reduced 
test ordering when a CDSS is embedded in the computerized physician order entry (CPOE) 
system (Algaze et al., 2016; Delvaux et al., 2017; Konger et al., 2016; Procop et al., 2015). The 
CDSS for type and screen ordering is similar to other systems used in our CPOE system 
designed to encourage best ordering practices. Our CDSS was embedded in our CPOE system 
and appears each time a provider initiates a type and screen order. It informs the provider of the 
blood type if one is on file, date and time the current test expires, and the date and time of the 
most recent test (Figure 1).  
The CDSS is strictly an informative system and does not block ordering of the test. 
Orders may be placed as a one-time test, STAT, routine laboratory collection, or the order may 
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be cancelled. The Pathology informatics team conducted internal testing to confirm the CDSS 
appeared when type and screen tests were ordered. No training or notification of the CDSS was 
offered to the providers prior to implementation.  
Instrumentation/Measurements/Procedures 
To determine the effectiveness of the CDSS on type and screen tests ordered, the total 
numbers of both appropriately and unnecessarily ordered tests were collected over three months 
pre-CDSS implementation and three months post-CDSS implementation. The same three 
calendar months were used for the pre-intervention period (March 1 to May 31, 2017) and the 
post-intervention period (March 1 to May 31, 2018). The total number of type and screen tests 
performed each month was captured in an aggregate report from the laboratory information 
system. Next, the pathology informatics team, using information from the CPOE system, the 
laboratory information system, and transfusion management software system, created a detailed 
spreadsheet to capture the data. Unnecessary tests were identified as those tests ordered if the 
specimen was collected before the previous specimen expired.  
Using the time-driven activity-based costing (TDABC) model (Kaplan & Anderson, 
2004), the estimated cost before and after the intervention was determined as a sum of the direct 
cost and the labor cost (Table 1) for all unnecessarily ordered tests. Direct costs are the materials 
and equipment needed to perform a single test. Our direct costs were $1.86/ test. Cost of the 
laboratory instruments was not included because our vendor agreement waives equipment and 
service fees. Labor cost is the time it takes an employee to perform a single type and screen test 
including drawing the blood and processing the specimen. Labor cost is estimated by using the 
employee’s average hourly salary divided by 60 to achieve the labor cost per minute then 
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multiplied by the number of minutes it takes to perform the test (K. Lee, personal 
communication, March 26, 2018).  
To account for nurse versus phlebotomist drawing the blood, labor costs were determined 
using phlebotomists’ mean hourly salary ($18.52) for 30 (61%) patient care units and nurses’ 
mean hourly salary ($36.18) for 19 (39%) patient care units for both pre- and post-CDSS 
implementation.  
To study unnecessary test ordering by different provider types, we used the spreadsheet 
created by the pathology informatics team that identified unnecessarily ordered tests. Systematic 
sampling was used to select 801 specimens each from the pre- and post-intervention periods. The 
remaining specimens were deleted. The provider name was used to determine the ordering 
provider type (i.e., physician, APRN, PA). Coding of specimen date for pre- or post-intervention 
and ordering provider type took place once the sample data were abstracted.  
One member of the research team was responsible for all data collection and entered all 
data into a data collection spreadsheet. An internal reviewer validated the accuracy of data entry 
for 11% of the pre- and 11% of the post-implementation sample data after the medical record 
numbers, order numbers, specimen numbers, and provider names were deleted to de-identify the 
data. Systematic sampling was used to select the specimens included for the check on data entry 
accuracy and all data points were identified as accurate.  
Data Analysis Plan 
The data were uploaded to IBM Statistical Package for the Social Sciences (SPSS) for 
analysis. To evaluate the total number of unnecessarily ordered type and screens, a sum of all 
unnecessary tests for the three-months before and after the CDSS intervention was divided by the 
total number of orders for each time period to achieve the percentage of unnecessary tests. To 
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determine the difference between the pre- and post-CDSS ordering, a chi-square test was 
calculated with a level of significance set at 0.05. 
Cost estimates were determined for all unnecessarily ordered type and screen tests during 
the pre-intervention and post-intervention periods. The pre- and post-intervention estimates were 
each multiplied by four to estimate the yearly cost savings. 
To describe the unnecessary type and screen tests ordered by physicians, APRNs, and 
PAs, we compared a number of unnecessary specimens for the pre-intervention and the post-
intervention time periods.  
Results 
There were a total of 26,206 pre- and 25,053 post-intervention specimens. Significantly 
fewer unnecessary type and screen tests were ordered after the CDSS intervention (12.3%, 
n=3,073) than before (14.1%, n=3,691; p<0.001; Table 2) demonstrating a 16.7% reduction. 
A TDABC model estimate was calculated to determine the dollars saved per year with 
the implementation of a CDSS for type and screen tests. The estimated annual cost of 
unnecessary type and screen tests pre-CDSS was $851,744 versus $709,132 post-CDSS 
implementation. The reduced number of unnecessary type and screen tests after implementation 
of the CDSS resulted in an estimated yearly savings of $142,612 in combined direct and labor 
costs compared to the pre-CDSS period. 
We also evaluated the ordering practices of unnecessary type and screen tests by provider 
type before versus after implementation of the CDSS. Physicians were the largest group of 
providers employed at our medical center both pre-intervention (n=2,218, 75%) and post-
intervention (n=2,071, 72%). The number of APRNs employed increased by 1.92% in the post-
intervention period (n=570, 20%) compared to the pre-intervention (n=534, 18%) while the 
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number of PAs employed remained essentially the same in the pre (n=211, 7%) and post groups 
(n=217, 8%). Of the providers employed by the medical center who actually wrote type and 
screen orders, the majority of the tests were ordered by physicians (85.3% before and 83.1% 
after the intervention) compared to APRNs and PAs (Table 3). Fewer unnecessary type and 
screen tests were ordered by physicians and PAs (-2.2%, -1.5% respectively) after the 
intervention than before while APRN type and screen ordering increased by 3.6%. 
Discussion 
Our study demonstrated that a CDSS appearing at the time of type and screen test 
ordering is an effective strategy to reduce the overall number of unnecessarily ordered tests. Our 
findings are in agreement with previous studies that leveraged CDSS as a means to reduce 
unnecessary phlebotomy testing (Algaze et al., 2016; Breen et al., 2018; Eaton et al., 2017; Kim, 
Dzik, Dighe, & Lweandowski, 2011; Krasowski et al., 2015; Procop et al., 2015). A common 
theme in the previous literature on this matter was that reductions to laboratory ordering 
practices requires the use of CDSSs in addition to other interventions. The most effective 
reductions of unnecessary ordering involved combinations of CDSS implementation, education, 
auditing, and feedback (Bindraban et al., 2018; Breen et al., 2018; Delvaux et al., 2017; Eaton et 
al., 2017; Khalifa & Khalid, 2014). However, similar to Najafi, Cucian, Poerre, and Khanna 
(2018), we achieved a statistically significant reduction in unnecessary ordering practices by 
implementing the CDSS alone. Part of our success may be attributed to the familiarity of our 
providers with using CDSSs and alerts within the EHR. Our CDSS had the desired 
characteristics of providing the right information at the time of decision-making, to the right 
people, and in the right format (HealthIT.gov, n.d.). Despite the reduction in unnecessary tests 
ordered after the CDSS implementation, the number of unnecessary tests remains unacceptably 
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high. Ordering practices may have undergone a greater change had implementation been 
augmented with organizational goals, education, auditing, and feedback. 
Comparing pre- and post-intervention estimated cost of unnecessary type and screens 
using the TDABC model, we found a yearly savings of $142,612. While several studies have 
reported cost savings associated with the use of CDSS, we believe we are the first to apply the 
TDABC model to reduced phlebotomy testing and were encouraged by the extent of the annual 
cost savings achieved for a low-cost, high-frequency test. 
Other studies have established a cost savings after implementing CDSSs that encourage 
best practice laboratory testing (Algaze et al., 2016; Eaton et al., 2017; Procop et al., 2015; 
Sadowski, Lane, Wood, Robinson, & Kim, 2017). Our study supported the existing literature and 
provides a unique estimation of cost that encompasses direct and indirect costs rather than using 
administrative charges or reimbursement fee schedules. Because implementation of the type and 
screen CDSS in our EHR was not an additional expense on top of vendor fees, any amount of 
cost savings was a benefit for our patients and organization.  
Low-cost, high-frequency tests have been shown to be used more often and account for a 
greater percentage of overall healthcare costs than high-priced tests (Mafi et al., 2017). Lack of a 
national policy on unnecessary ordering practices combined with existing quality measures that 
evaluate for underuse rather than overuse may influence a provider’s decision to order tests 
unnecessarily. Unnecessary ordering occurs among both private and publicly insured patients 
(Charlesworth, Meath, Schwartz, & McConnell, 2016) suggesting that all populations could 
achieve waste reduction with the use of CDSS.  
Although we found that all provider types ordered unnecessary type and screen tests, 
there is more work is required to improve appropriate utilization. We noted mixed results of 
REDUCING UNNECESSARY PHLEBOTOMY TESTING USING A 12 
 
ordering practices by provider type after CDSS implementation (physicians 83.1%, APRN 10%, 
PA 6.9%: Table 3). After evaluating the number of unnecessary tests for each provider type pre- 
and post-CDSS implementation, we can speculate the increase in APRN unnecessary orders after 
the intervention may have been attributed to an increased number of APRNs employed before 
and after the intervention (pre- 534, post- 570). However, because we did not collect data on the 
total number of providers who actually ordered type and screen tests or the number of orders 
written by each provider for multiple patients, we could not perform inferential statistics to 
further evaluate the data. While we were unable to find literature specifically about phlebotomy 
test ordering by provider type, current literature did not clearly identify one provider type 
exercising more appropriate test ordering than another (Carryer, Askew, Hodge, Miller, & 
Gibbons, 2011; Hughes, Jiang, & Duszak, 2015; Mafi, Wee, Davis, & Landon, 2016; Winchester 
et al., 2014). CDSSs can alter actions at the time of ordering but it is not known if they contribute 
to changing ordering habits or attitudes (Delvaux et al., 2017).  
In our academic hospital setting it is well known that physician residents write the 
majority of patient orders. Teaching ordering best practices early in physicians’ training can 
shape career-long habits. Learning more about ordering habits of different provider types is 
relevant as organizations move towards using more advanced practice clinicians and are 
challenged to contain costs while providing quality care. 
Limitations 
Our study had several limitations. First, it was conducted in a single academic institution 
familiar with CPOE and CDSSs. Generalizability of findings to other settings new to CPOE and 
CDSS is unclear. Second, results could differ in a non-academic setting where providers are no 
longer training and influenced by senior providers. Third, we did not differentiate ordering 
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practices among attending, fellow, or resident physicians. We did not account for the fact that 
particular providers may have ordered multiple unnecessary tests while others may have ordered 
one or none. Finally, we assessed the effect of a CDSS on one specific phlebotomy test. While 
we believe type and screen test ordering provides understanding of ordering practices and 
phlebotomy specimen costs, defining unnecessary ordering for other tests may be more 
challenging.  
Implications/Recommendations for Practice, Policy, and Research 
Our study illustrated the effectiveness of CDSS as a means of reducing unnecessary 
health care services. CPOE is widely used in a variety of health care settings and can incorporate 
CDSS to guide all provider types in making judicious decisions at the time of care. However, 
achieving greater reductions in unnecessary testing at our institution demands additional 
interventions including organizational support, education, audits, and feedback.  
Reducing unnecessary tests requires high level organizational support and 
acknowledgment that it fits into an organization’s strategic aim at quality care. Instituting 
incremental goals to reduce unnecessary low-cost, high frequency testing can establish internal 
quality measures reported to quality care committees and change the ordering habits of all 
provider types. Starting at the highest level with the Hospital Quality Improvement Council, we 
recommend an institutional mandate to reduce the rate of unnecessarily ordered type and screens 
by 2% each year for the next three years. We further recommend that departments that do not 
meet the target reduction goal of 2% at the end of each year be required to provide the Quality 
Improvement Council with a detailed action plan on how they will achieve the goal the following 
year. Moreover, the success of top performing departments and their improvement strategies 
should be highlighted in the hospital’s internal newsletter. 
REDUCING UNNECESSARY PHLEBOTOMY TESTING USING A 14 
 
We also recommend the appointment of champions from the departments of surgery and 
medicine as well as the Advanced Practice Provider Committee to disseminate test ordering 
practices, hold senior level providers accountable for adhering to evidence-based phlebotomy 
ordering, and educate new staff and trainees. We recommend that education on reducing 
unnecessary testing take place in formal settings such as: new-hire onboarding, annual 
competency training, lectures, grand rounds, daily patient rounds, and just-in-time learning 
opportunities.  
Traditional auditing is labor intensive, but by leveraging the CPOE system using data 
analytics, quality improvement departments can provide data displays and analysis to identify 
areas for improvement. Our recommendation is to provide ongoing auditing of phlebotomy test 
ordering practices of individual providers to learn about individual, departmental, and 
organizational ordering patterns.  
Until the establishment of national quality measures aimed to control the number of low-
cost, high-frequency tests, each health care system must explore ways to locally identify and 
reduce unnecessary health services. Implementation of CDSS in combination with organizational 
support, education, auditing and feedback provide a ground level structure to reduce unnecessary 
testing. Further research is needed to determine which tests should be targeted using CDSSs 
without adversely affecting patient outcomes. In this era of precision healthcare, the upshot of 
ordering the right test, at the right time, for the right reason can reduce cost, reduce waste, and 
improve quality, outcomes, and satisfaction for patients. 
Sustainability 
Our CDSS to reduce unnecessary type and screen testing was a systems level change that 
will remain in our CPOE system. We believe that it will continue to reduce unnecessary type and 
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screen ordering but additional interventions will be instituted to achieve further substantial and 
sustainable reductions: strong leadership, education, performance auditing, and feedback.  
Conclusions 
Unnecessary testing continues in health care and contributes to excessive health 
spending. Phlebotomy testing is one example of how providers can reduce waste and control 
healthcare costs for low-cost, high-frequency tests. Our study demonstrated that CDSSs 
impacted a variety of provider types, reduced unnecessary phlebotomy tests, and achieved yearly 
cost savings. 
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Figure 1. Clinical decision support system for type and screen test (all data and patient 
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Table 1  
Time-driven Activity-based Estimated Cost for Type and Screen Test 
Direct costs    
Testing materials 
and reagents 
$1.86/ test   
Blood bank analyzer $185,000 x 2 
analyzers + $24,700 
per year service fee* 
  
Labor costs Labor cost per 
minute based on 




Number of patient 
care units 
Nurse cost for 
drawing specimen 








$0.31/test 120 minutes N/A 
*Not included in cost calculation; vender agreement waived equipment and service fees 
  




Unnecessary Type and Screen Tests Ordered Before Versus After the Implementation of a 
Clinical Decision Support System 
  
Total  
n (%)  
Appropriate order 
n (%)  
Unnecessary order 





Pre-CDSS 26206 (100) 22515 (85.9) 3691 (14.1)  36.98 <0.001  











Unnecessary Type and Screen Tests Ordered by Provider Type Before Versus After the 









Pre-CDSS 801 (50) 683 (85.3) 51 (6.4) 67 (8.4) 
Post-CDSS  801 (50) 666 (83.1) 80 (10) 55 (6.9) 
Total 1602 (100) 1349 (84.2) 131 (8.2) 122 (7.6) 
 
Note: We did not collect data on the total number of providers who actually wrote type and 
screen orders, or the number of orders written by each provider during the study period and 
therefore, we were unable to perform inferential statistics to further evaluate the data. 
 
 
 
